1. Home
  2. ARE vs NTRA Comparison

ARE vs NTRA Comparison

Compare ARE & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARE
  • NTRA
  • Stock Information
  • Founded
  • ARE 1994
  • NTRA 2003
  • Country
  • ARE United States
  • NTRA United States
  • Employees
  • ARE N/A
  • NTRA N/A
  • Industry
  • ARE Real Estate Investment Trusts
  • NTRA Medical Specialities
  • Sector
  • ARE Real Estate
  • NTRA Health Care
  • Exchange
  • ARE Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • ARE 17.5B
  • NTRA 18.4B
  • IPO Year
  • ARE 1997
  • NTRA 2015
  • Fundamental
  • Price
  • ARE $93.17
  • NTRA $138.00
  • Analyst Decision
  • ARE Hold
  • NTRA Strong Buy
  • Analyst Count
  • ARE 9
  • NTRA 17
  • Target Price
  • ARE $120.00
  • NTRA $179.00
  • AVG Volume (30 Days)
  • ARE 1.1M
  • NTRA 1.9M
  • Earning Date
  • ARE 04-28-2025
  • NTRA 05-08-2025
  • Dividend Yield
  • ARE 5.52%
  • NTRA N/A
  • EPS Growth
  • ARE 233.15
  • NTRA N/A
  • EPS
  • ARE 1.80
  • NTRA N/A
  • Revenue
  • ARE $3,123,453,000.00
  • NTRA $1,696,911,000.00
  • Revenue This Year
  • ARE N/A
  • NTRA $13.56
  • Revenue Next Year
  • ARE $4.63
  • NTRA $18.11
  • P/E Ratio
  • ARE $53.14
  • NTRA N/A
  • Revenue Growth
  • ARE 8.20
  • NTRA 56.75
  • 52 Week Low
  • ARE $93.25
  • NTRA $83.13
  • 52 Week High
  • ARE $130.14
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • ARE 42.03
  • NTRA 41.35
  • Support Level
  • ARE $95.06
  • NTRA $146.35
  • Resistance Level
  • ARE $97.67
  • NTRA $155.64
  • Average True Range (ATR)
  • ARE 2.26
  • NTRA 6.42
  • MACD
  • ARE -0.42
  • NTRA 0.87
  • Stochastic Oscillator
  • ARE 9.17
  • NTRA 51.93

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: